SCHEMBL23309708

SCHEMBL23309708

O=C(Nc1ccc(Cl)cc1)c1cc(F)nc(F)c1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.52
▸ NPC1 O15118 3/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ P2RX1 P51575 3/20 0.51
▸ HDAC8 Q9BY41 2/20 0.46
▸ NR3C1 P04150 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ JAK2 O60674 2/20 0.44
▸ JAK1 P23458 2/20 0.44
▸ TYK2 P29597 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ AHR P35869 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ P2RX4 Q99571 1/20 0.44
▸ P2RX7 Q99572 1/20 0.44
▸ TMPRSS4 Q9NRS4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309730 0.92 KMT2A (0.47) RAB9ANPC1KMT2ALMNAALDH1A1
SCHEMBL23309502 0.88 NFKB1 (0.51) RAB9ANPC1KMT2AALDH1A1SMN1; SMN2
SCHEMBL23309495 0.87 FADS1 (0.56) RAB9ANPC1KMT2ALMNAALDH1A1
SCHEMBL23309703 0.85 RAB9A (0.51) RAB9ANPC1KMT2ALMNAALDH1A1
SCHEMBL23309621 0.85 RAB9A (0.50) RAB9ANPC1KMT2ALMNAALDH1A1
SCHEMBL23309490 0.85 GAA (0.51) RAB9ANPC1KMT2ALMNAALDH1A1
SCHEMBL23309548 0.85 FADS1 (0.55) RAB9ANPC1KMT2ALMNAALDH1A1
SCHEMBL23309531 0.85 MAOB (0.49) RAB9ANPC1KMT2ASMN1; SMN2
SCHEMBL23309714 0.85 POLB (0.51) RAB9ANPC1LMNAALDH1A1SMN1; SMN2
SCHEMBL23309555 0.84 HTT (0.55) RAB9ANPC1MAPK1JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL RAB9A 286/4885NPC1 412/4885KMT2A 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback